The bioactive NPs reduced lactate production in cancer cells (in association with PKM2-mediated glycolytic inhibition) and skewed macrophages towards a proinflammatory phenotype, characterized by a higher production of TNF-α and lower secretion of TGF-β. The gene discussed is PKM; the disease is cancer.